Integral Health Asset Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100,000
Closed -$10.6M 98
2025
Q4
$10.6M Sell
100,000
-100,000
-50% -$11.6M 0.53% 58
2025
Q3
$25.4M Sell
200,000
-120,000
-38% -$14.3M 1.72% 15
2025
Q2
$39.2M Buy
320,000
+50,000
+19% +$5.71M 3.59% 4
2025
Q1
$27.3M Sell
270,000
-30,000
-10% -$2.93M 2.91% 9
2024
Q4
$27.7M Buy
300,000
+25,000
+9% +$2.45M 2.36% 10
2024
Q3
$26.6M Sell
275,000
-25,000
-8% -$2.25M 2.99% 9
2024
Q2
$25.7M Sell
300,000
-50,000
-14% -$4.2M 2.45% 11
2024
Q1
$28.9M Buy
350,000
+100,000
+40% +$7.32M 2.68% 7
2023
Q4
$16.7M Hold
250,000
2.27% 11
2023
Q3
$16.8M Buy
250,000
+30,000
+14% +$2.06M 2.32% 15
2023
Q2
$14.9M Buy
+220,000
New +$13.8M 1.84% 13
2021
Q1
Sell
-87,990
Closed -$5.79M 77
2020
Q4
$5.79M Buy
+87,990
New +$5.18M 1.72% 24
2020
Q2
Sell
-144,555
Closed -$7.36M 69
2020
Q1
$7.36M Buy
+144,555
New +$8.33M 3.24% 10

Other funds holding EHC

Integral Health Asset Management's EHC Position: Q1 2026 in Review

Integral Health Asset Management sold out of Encompass Health (EHC) in Q1 2026, closing a stake of 100,000 shares — an estimated $10.6M sold.

Integral Health Asset Management first reported a position in EHC in Q1 2020 and held it in 13 quarters. The position peaked at $39.2M in Q2 2025. 580 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Integral Health Asset Management reported no remaining Encompass Health position as of Q1 2026 after selling out during the quarter.
  • Integral Health Asset Management sold 100,000 Encompass Health shares in Q1 2026, an estimated $10.6M.
  • Integral Health Asset Management first reported a position in Encompass Health in Q1 2020 and held it in 13 quarters.
  • Integral Health Asset Management's Encompass Health position peaked at $39.2M in Q2 2025.
  • 580 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.